FDA panel unanimously endorses Eisai's Alzheimer's drug

By STAT News
| June 12, 2023

Expert advisers to the FDA voted unanimously in favor of expanding the approval of Leqembi, an Alzheimer's disease treatment from Eisai and Biogen.

Full story

#1

Physicians are in short supply. They are costly. Is the APP the answer to the CMO's workforce and budget challenges? ...

Amid the hype and promise, a growing tension is becoming clear: the reality of what AI can deliver versus what it can't. ...